HeartSciences (HSCS) Shareholder's Equity (QoQ) (2021 - 2026)
HeartSciences (HSCS) Shareholder's Equity (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -36.59% |
| Oct 31, 2025 | 33.15% |
| Jul 31, 2025 | 1,430.97% |
| Apr 30, 2025 | -88.52% |
| Jan 31, 2025 | -55.52% |
| Oct 31, 2024 | -32.31% |
| Jul 31, 2024 | -18.91% |
| Apr 30, 2024 | -15.25% |
| Jan 31, 2024 | 623.36% |
| Oct 31, 2023 | -217.43% |
| Jul 31, 2023 | -325.41% |
| Apr 30, 2023 | 189.39% |
| Jan 31, 2023 | -123.82% |
| Oct 31, 2022 | -62.50% |
| Jul 31, 2022 | 147.68% |
| Apr 30, 2022 | -47.64% |
| Jan 31, 2022 | -19.16% |
| Oct 31, 2021 | -42.93% |